Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06729086Not yet recruiting
Randomised trial of sevoflurane in coronary artery disease (CAD) and heart valve disease (VHD) (2 arms), sponsored by Saint Joseph's University. Primary endpoint: Relationship between myocardial protection and type of anesthesia. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06729086.